Questcor Pharmaceuticals Receives Average Rating of “Hold” from Analysts (NASDAQ:QCOR)
Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) have received an average recommendation of “Hold” from the ten ratings firms that are covering the company, StockRatingsNetwork.com reports. Seven equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $84.44.
Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) opened at 93.60 on Thursday. Questcor Pharmaceuticals has a 52-week low of $47.71 and a 52-week high of $97.80. The stock’s 50-day moving average is $92.90 and its 200-day moving average is $81.15. The company has a market cap of $5.587 billion and a P/E ratio of 16.41.
Questcor Pharmaceuticals (NASDAQ:QCOR) last released its earnings data on Thursday, July 24th. The company reported $1.85 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.74 by $0.11. The company had revenue of $278.80 million for the quarter, compared to the consensus estimate of $261.02 million. During the same quarter in the prior year, the company posted $1.12 earnings per share. The company’s quarterly revenue was up 38.5% on a year-over-year basis. On average, analysts predict that Questcor Pharmaceuticals will post $6.73 earnings per share for the current fiscal year.
Separately, analysts at Oppenheimer downgraded shares of Questcor Pharmaceuticals from an “outperform” rating to a “market perform” rating in a research note on Friday, July 25th. They now have a $86.00 price target on the stock.
In other Questcor Pharmaceuticals news, Insider Don M. Bailey sold 40,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $91.96, for a total transaction of $3,678,400.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.